Canopy Growth Set to Acquire Beckley Canopy Therapeutics

Canopy Growth Corporation CGC recently signed an agreement to acquire global cannabinoid-based medical researcher Beckley Canopy Therapeutics. The acquisition will integrate Canopy Growth’s wholly-owned research program with the Beckley Canopy research platform, which is partly owned by Canopy Growth. As part of the acquisition, Canopy Growth will be acquiring the outstanding shares in Spectrum Biomedical UK, the commercial arm of the company in the United Kingdom.

With this acquisition, Canopy Growth’s research and development endeavors would be expanding worldwide, thereby making the company a global pioneer in cannabinoid research.


Leave a Reply